2018 EHRA/ESC WGT/EAPCI/ACCA Joint European Consensus Document on the Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Cardiovascular Interventions

July 21, 2018—In recognizing advances since the 2014 consensus document, the European Heart Rhythm Association (EHRA), the European Society of Cardiology Working Group on Thrombosis, the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and the European Association of Acute Cardiac Care (ACCA) developed a focused update to include the new data, with the remit of comprehensively reviewing the available evidence and publishing a focused update consensus document on the management of antithrombotic therapy in patients with atrial fibrillation presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions (e.g., transcatheter aortic valve replacement), and providing up-to-date consensus recommendations for use in clinical practice.